Inogen, Inc. (NASDAQ: INGN) is a Healthcare company (Medical - Devices) with a market capitalization of $148M. The Maz Rating grades it against the other companies in its sector.
Inogen, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $5.68, Inogen, Inc. trades at 0.4x sales and 1.0x book value. Over the last twelve months it generated about $339M of revenue and a net loss of $34M. It runs a gross margin of 47.3%, an operating margin of -11.3% and a net margin of -10.5%. It shows return on equity of -20.1%, return on invested capital of -19.2% and a free cash flow yield of -8.6%. On the balance sheet: a debt-to-equity ratio of 0.10 and a current ratio of 2.96. Over the past 52 weeks the share price ranged from $5.04 to $7.67, with a beta of 1.49.
Inogen, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 6 Buy, 4 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.